Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
897. American Thoracic Society, Centers <strong>for</strong> Disease <strong>Control</strong> <strong>and</strong> Prevention. Targeted<br />
tuberculin testing <strong>and</strong> treatment of latent tuberculosis infection. Am J Respir<br />
Crit Care Med 2000; 161 (Suppl): S221-S247.<br />
898. Citron KM. <strong>Control</strong> <strong>and</strong> prevention of tuberculosis: a code of practice. BMJ<br />
1983; 287: 1118-21.<br />
899. Subcommittee of the Joint <strong>Tuberculosis</strong> Committee of the British Thoracic<br />
Society. Guidelines on the management of tuberculosis <strong>and</strong> HIV infection in the<br />
United Kingdom. BMJ 1992; 304: 1231-3.<br />
900. Lecoeur HF, Truffot-Pernot C, Grosset JH. Experimental short-course preventive<br />
therapy of tuberculosis with rifampin <strong>and</strong> pyrazinamide. Am Rev Respir<br />
Dis 1989; 140: 1189-93.<br />
901. Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH,<br />
Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R,<br />
Chaisson RE. R<strong>and</strong>omised trial of isoniazid versus rifampicin <strong>and</strong> pyrazinamide<br />
<strong>for</strong> prevention of tuberculosis in HIV-1 infection. Lancet 1998; 351: 786-92.<br />
902. Gordin F, Chaisson RE, Matts JP, de Lourdes Garcia M, Hafner R, Valdespino JL,<br />
Coberly J, Schecter M, Klukowicz AJ, Barry MA, O’Brien RJ. Rifampin <strong>and</strong><br />
pyrazinamide vs isoniazid <strong>for</strong> prevention of tuberculosis in HIV-infected patients.<br />
An international r<strong>and</strong>omized trial. JAMA 2000; 283: 1445-50.<br />
903. Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, Godfrey-<br />
Faussett P. Long-term effect of preventive therapy <strong>for</strong> tuberculosis in a cohort<br />
of HIV-infected Zambian adults. AIDS 2001; 15: 215-22.<br />
904. Centers <strong>for</strong> Disease <strong>Control</strong> <strong>and</strong> Prevention. Fatal <strong>and</strong> severe hepatitis associated<br />
with rifampin <strong>and</strong> pyrazinamide <strong>for</strong> the treatment of latent tuberculosis infection<br />
- New York <strong>and</strong> Georgia, 2000. Morb Mortal Wkly Rep 2001; 50: 289-91.<br />
905. Aisu T, Raviglione MC, Van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G,<br />
McFarl<strong>and</strong> D, Engwau FA. Preventive chemotherapy <strong>for</strong> HIV-associated tuberculosis<br />
in Ug<strong>and</strong>a: an operational assessment at a voluntary counselling <strong>and</strong> testing<br />
centre. AIDS 1995; 9: 267-73.<br />
906. Kochi A. The global tuberculosis situation <strong>and</strong> the new control strategy of the<br />
World Health Organization. (Leading article). Tubercle 1991; 72: 1-6.<br />
907. World Health Organization, UNAIDS. Policy statement on preventive therapy<br />
against tuberculosis in people living with HIV. Report of a meeting held in<br />
Geneva 18 - 20 February 1998. WHO/TB/98.255: Geneva: WHO, 1998; 1-26.<br />
908. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy <strong>for</strong><br />
tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997; 25:<br />
872-87.<br />
909. Bell WJ, Brown PP, Horn DW. Prednisolone in the treatment of acute extensive<br />
pulmonary tuberculosis in West Africans. Tubercle 1960; 41: 341-51.<br />
230
Change language